Veterinary Medicines

FEVAXYN QUATRIFEL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΓΑΤΕΣ

Authorised
  • Feline panleucopenia virus, strain CU4, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Feline rhinotracheitis virus, strain 605, Inactivated
  • Chlamydia felis, strain Cello, Inactivated
Download as PDF

Product identification

Medicine name:
FEVAXYN QUATRIFEL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΓΑΤΕΣ
Active substance:
  • Feline panleucopenia virus, strain CU4, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Feline rhinotracheitis virus, strain 605, Inactivated
  • Chlamydia felis, strain Cello, Inactivated
Target species:
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain CU4, Inactivated
    8.50
    relative potency
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain 255, Inactivated
    1.26
    relative potency
    /
    1.00
    millilitre(s)
  • Feline rhinotracheitis virus, strain 605, Inactivated
    1.39
    relative potency
    /
    1.00
    millilitre(s)
  • Chlamydia felis, strain Cello, Inactivated
    1.69
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AL02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 20535/17/23-07-2018/K-0214602
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."